LifeStance Health Group (LFST) P/S ratio

P/S ratio today
3.9×

LifeStance Health Group (LFST) trades at 3.9× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 1.9×. That is 13.4% lower than the 2.2× of fiscal 2024. Figures as of 17 Nov 2026, 22:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
3.9×
P/S ratio, fiscal 2025
1.9×
Change on fiscal 2024
−13.4%
Highest on record
2.7×fiscal 2023
Lowest on record
1.9×fiscal 2025
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

LifeStance Health Group P/S ratio, in more detail

Today's figure is 101.3% above the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2021–2025), the highest was 2.7× in fiscal 2023 and the lowest 1.9× in fiscal 2025. Today's P/S ratio is above every one of the 5 fiscal year-ends on record; their median is 2.2×.

History · 5 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

LifeStance Health Group P/S ratio, year by year

LifeStance Health Group (LFST) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today3.9×—$14.17—
20251.9× 13.4% down$7.04$3.64
20242.2× 18.0% down$7.37$3.30
20232.7× 33.5% up$7.83$2.87
20222.0× 5.4% down$4.94$2.42
20212.2×—$9.52$4.41

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of LifeStance Health Group and comparable companies
CompanyP/S ratio
LifeStance Health Group LFST3.8×
BillionToOne BLLN15.3×
Hims & Hers Health HIMS1.8×
PTC Therapeutics PTCT2.9×
Haemonetics HAE4.1×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on LFST

LifeStance Health Group, figure by figure

LifeStance Health Group (LFST) overview: price, valuation and scorecardAll health care companies by market value

LifeStance Health Group P/S ratio: questions and answers

What is LifeStance Health Group's P/S ratio?

LifeStance Health Group (LFST) trades at 3.9× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 1.9×. That is 13.4% lower than the 2.2× of fiscal 2024.

Is LifeStance Health Group's P/S ratio high or low compared with its own history?

Today's P/S ratio is above every one of the 5 fiscal year-ends on record; their median is 2.2×.

What are the highest and lowest P/S ratio figures on record for LifeStance Health Group?

Across the 5 fiscal year-ends on record (2021–2025), the highest was 2.7× in fiscal 2023 and the lowest 1.9× in fiscal 2025.

How is LifeStance Health Group's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “LifeStance Health Group (LFST) P/S ratio”, data as of 17 November 2026. https://funkfolio.com/stock/LFST/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.